104 related articles for article (PubMed ID: 25739538)
1. Arsenite Interacts with Dibenzo[def,p]chrysene (DBC) at Low Levels to Suppress Bone Marrow Lymphoid Progenitors in Mice.
Ezeh PC; Lauer FT; Liu KJ; Hudson LG; Burchiel SW
Biol Trace Elem Res; 2015 Jul; 166(1):82-8. PubMed ID: 25739538
[TBL] [Abstract][Full Text] [Related]
2. Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo.
Ezeh PC; Lauer FT; MacKenzie D; McClain S; Liu KJ; Hudson LG; Gandolfi AJ; Burchiel SW
PLoS One; 2014; 9(4):e93920. PubMed ID: 24714590
[TBL] [Abstract][Full Text] [Related]
3. Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice.
Lauer FT; Walker MK; Burchiel SW
J Toxicol Environ Health A; 2013; 76(1):16-24. PubMed ID: 23151208
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Profiling of Dibenzo[def,p]chrysene-induced Spleen Atrophy Provides Mechanistic Insights into its Immunotoxicity in MutaMouse.
Chepelev NL; Long AS; Williams A; Kuo B; Gagné R; Kennedy DA; Phillips DH; Arlt VM; White PA; Yauk CL
Toxicol Sci; 2016 Jan; 149(1):251-68. PubMed ID: 26496743
[TBL] [Abstract][Full Text] [Related]
5. Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.
Harper TA; Morré J; Lauer FT; McQuistan TJ; Hummel JM; Burchiel SW; Williams DE
Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():51-6. PubMed ID: 25868132
[TBL] [Abstract][Full Text] [Related]
6. Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells.
Li Q; Lauer FT; Liu KJ; Hudson LG; Burchiel SW
Toxicol Appl Pharmacol; 2010 Jun; 245(3):344-51. PubMed ID: 20353797
[TBL] [Abstract][Full Text] [Related]
7. A Highly Abbreviated Synthesis of Dibenzo[def,p]chrysene and Its 12-Methoxy Derivative, a Key Precursor for the Synthesis of the Proximate and Ultimate Carcinogens of Dibenzo[def,p]chrysene.
Sharma AK; Kumar S; Amin S
J Org Chem; 2004 May; 69(11):3979-82. PubMed ID: 15153038
[TBL] [Abstract][Full Text] [Related]
8. Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[def,p]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry.
Madeen EP; Ognibene TJ; Corley RA; McQuistan TJ; Henderson MC; Baird WM; Bench G; Turteltaub KW; Williams DE
Chem Res Toxicol; 2016 Oct; 29(10):1641-1650. PubMed ID: 27494294
[TBL] [Abstract][Full Text] [Related]
9. The effect of inhibitors of phosphatidylinositol 3-kinase-related kinases on dibenzo[def,p]chrysene genotoxicity measured by γH2AX levels and neutral comet assay in HepG2 human hepatocellular cancer cells.
Kowalczyk K; Roszak J; Brodecki M; Domeradzka Gajda K; Szparaga M; Sobańska Z; Stępnik M
Toxicol In Vitro; 2020 Mar; 63():104749. PubMed ID: 31838185
[TBL] [Abstract][Full Text] [Related]
10. Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.
Pande P; Madeen EP; Williams DE; Crowell SR; Ognibene TJ; Turteltaub KW; Corley RA; Smith JN
Toxicol Appl Pharmacol; 2022 Mar; 438():115830. PubMed ID: 34933053
[TBL] [Abstract][Full Text] [Related]
11. The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2.
Spryszyńska S; Smok-Pieniążek A; Ferlińska M; Roszak J; Nocuń M; Stępnik M
Mutat Res Genet Toxicol Environ Mutagen; 2015 Sep; 791():12-24. PubMed ID: 26338538
[TBL] [Abstract][Full Text] [Related]
12. Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.
Crowell SR; Sharma AK; Amin S; Soelberg JJ; Sadler NC; Wright AT; Baird WM; Williams DE; Corley RA
Toxicol Sci; 2013 Sep; 135(1):48-62. PubMed ID: 23744095
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the genotoxicity of dibenzo[c,p]chrysene in human carcinoma MCF-7 cells in culture.
Mahadevan B; Luch A; Atkin J; Nguyen T; Sharma AK; Amin S; Baird WM
Chem Biol Interact; 2006 Dec; 164(3):181-91. PubMed ID: 17094953
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Toxicity in Mouse Bone Marrow Progenitor Cells.
Ezeh PC; Xu H; Wang SC; Medina S; Burchiel SW
Curr Protoc Toxicol; 2016 Feb; 67():18.9.1-18.9.12. PubMed ID: 26828331
[TBL] [Abstract][Full Text] [Related]
15. Human in Vivo Pharmacokinetics of [(14)C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing.
Madeen E; Corley RA; Crowell S; Turteltaub K; Ognibene T; Malfatti M; McQuistan TJ; Garrard M; Sudakin D; Williams DE
Chem Res Toxicol; 2015 Jan; 28(1):126-34. PubMed ID: 25418912
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivities of bone marrow, spleen and thymus to genotoxicity induced by environmentally relevant concentrations of arsenite.
Xu H; McClain S; Medina S; Lauer FT; Douillet C; Liu KJ; Hudson LG; Stýblo M; Burchiel SW
Toxicol Lett; 2016 Nov; 262():55-61. PubMed ID: 27659730
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of dibenzo[def,p]chrysene, its active metabolites, and their 13C-labeled analogues.
Xu D; Duan Y; Blair IA; Penning TM; Harvey RG
Org Lett; 2008 Mar; 10(6):1059-62. PubMed ID: 18284245
[TBL] [Abstract][Full Text] [Related]
19. Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring.
Shorey LE; Castro DJ; Baird WM; Siddens LK; Löhr CV; Matzke MM; Waters KM; Corley RA; Williams DE
Cancer Lett; 2012 Apr; 317(1):49-55. PubMed ID: 22085489
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of hydroquinone, benzoquinone, and doxorubicin on mouse and human bone marrow cells at physiological oxygen partial pressure.
Colinas RJ; Burkart PT; Lawrence DA
Toxicol Appl Pharmacol; 1994 Nov; 129(1):95-102. PubMed ID: 7974500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
